Related Experiment Video
Updated: Sep 27, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome
Ishith Seth1, Shyam Prakaash Bhagavata Srinivasan1, Gabriella Bulloch1
1Wagga Wagga Base Hospital Murrumbidgee Local Health District Wagga Wagga New South Wales Australia.
Abstract:
Diffuse alveolar haemorrhage (DAH) is a rare complication of antiphospholipid syndrome. With a mortality rate of 46%, early diagnosis and management remain an ongoing challenge. Case reports are limited, and management guidelines are not yet definitive. In this case report, we present a 43-year-old male with DAH who required high-dose oral steroids, intravenous methylprednisolone cyclophosphamide and rituximab over 18 months to control life-threatening episodes of pulmonary bleeding.
More Related Videos
Related Concept Videos
Pulmonary Embolism I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Peripheral Artery Disease I: Introduction

